Apraclonidine Hydrochloride and Disopyramide Sustained-Release Capsules
Determining the interaction of Apraclonidine Hydrochloride and Disopyramide Sustained-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apraclonidine ophthalmic
Brand name: Iopidine
Synonyms: Apraclonidine ophthalmic, Apraclonidine
Generic Name: disopyramide
Brand name: Norpace, Norpace CR
Synonyms: Disopyramide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apraclonidine Hydrochloride-DisperMox
- Apraclonidine Hydrochloride-Disposable Enema rectal
- Apraclonidine Hydrochloride-Disulfiram
- Apraclonidine Hydrochloride-Dithol Solution
- Apraclonidine Hydrochloride-Ditropan
- Apraclonidine Hydrochloride-Ditropan XL
- Disopyramide Sustained-Release Capsules-Apraclonidine ophthalmic
- Disopyramide Sustained-Release Capsules-Apremilast
- Disopyramide Sustained-Release Capsules-Aprepitant
- Disopyramide Sustained-Release Capsules-Aprepitant Capsules
- Disopyramide Sustained-Release Capsules-Aprepitant Injection
- Disopyramide Sustained-Release Capsules-Aprepitant Intravenous